On December 16, 2020, Dayton Misfeldt provided notice of resignation from his positions with Sunesis Pharmaceuticals, Inc. as principal financial officer, effective as of December 31, 2020, in order to pursue another opportunity. In addition, on December 16, 2020, the Board appointed Tina Gullotta, Vice President, Finance and principal accounting officer as principal financial officer, effective January 1, 2021. Ms. Gullotta joined in August 2018 with extensive experience in accounting, finance, and investor relations in the biotech industry. Prior to joining Sunesis, Ms. Gullotta was the Corporate Controller and held various other management positions at Atara Biotherapeutics, Inc.